WNX
NEUTRALWellnex Life Limited Issues New Shares
The consumer healthcare company has issued new ordinary shares to settle fees related to its AIM admission.
Wellnex Life Limited
15.50GBX
0.00%
Market Cap
10.50M
Volume
787
2% of avg
P/E Ratio
EPS (TTM)
Beta
0.99
Day Range
0.00p - 0.00p
52 Week Range
0.00p15.50p31.30p
15.50p
Upcoming Events
WNX
GOODWellnex Life Reports Strong Revenue Growth in Trading Update
The consumer healthcare business reported a 46% increase in revenue for the first four months of 2025, with April sales up 75% year-over-year. The company also extinguished debt and achieved cost savings from its recent AIM listing.
WNX
NEUTRALWellnex Life Announces Board and Management Changes
The consumer healthcare company announces changes to its board and management team, including the resignation of the Non-Executive Chairman and the appointment of an interim replacement.
WNX
NEUTRALWellnex Life Announces Holding Change
The retailer has announced a change in its major shareholding, with Pentwater Capital Management LP increasing its stake in the company.
WNX
NEUTRALWellnex Life Appoints UK Distributor Powermed Plus to Expand Brands
The health and wellness company has secured a distribution partner to introduce its brands to the UK market, as part of its international expansion strategy.
WNX
VERY GOODWellnex Life Delivers Strong Q3 FY25 Results, Completes AIM Listing
The consumer healthcare business reported a 35% increase in Q3 sales, driven by strong performance in its own brands and IP licensing. The company also completed its AIM listing, enabling cost savings.
WNX
NEUTRALWellnex Life Announces Director Dealings
The health and wellness company has announced changes to its major shareholders.
WNX
GOODWellnex Life Completes £0.155m Retail Offer
The consumer health company has raised £0.155m through a retail offer, with the funds to be used for new business development opportunities.
WNX
NEUTRALWellnex Life issues shares to settle Pain Away acquisition
The health and wellness company has issued new shares to settle deferred consideration for a previous acquisition.
You're all caught up!